Skip to content

A Study to Evaluate the Effect of Mallasindhoor in the Treatment of Tamaka Shwasa (Bronchial Asthma)

Clinical and in vivo study of Mallasindhoor in Tamaka Swasa (Bronchial Asthama) - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104250
Enrollment
30
Registered
2026-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

None listed

Sponsors

Dr Pallavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients between 18 to 60 years of age irrespective of sex 2 Subjects having complaints of a Breathing difficulty b Wheezing c Chest tightness 3 Mild Asthmatic patient s with Raised AEC and IgE

Exclusion criteria

Exclusion criteria: 1 Patients below 18 years and above 60 years 2 Pregnancy and lactating mother 3 Any cardiac problem 4 Any psychiatric problems 5 Cancer patients 6 Surgical intervention if any 7 Patient of COPD

Design outcomes

Primary

MeasureTime frame
Decreasing the severity of Shwasa Krichrata and KasaTimepoint: 15th and 30th day

Secondary

MeasureTime frame
Decreasing the severity of Gurgurata Asino Labhate Sukham ParshwashulaTimepoint: 15th and 30th day

Countries

India

Contacts

Public ContactDr Manas Das

Government Ayurvedic College and Hospital Guwahati

rkslavia1972@gmail.com8638211399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026